about
Application of self-organizing maps in compounds pattern recognition and combinatorial library design.P-glycoprotein substrate models using support vector machines based on a comprehensive data set.One-pot Synthesis of Soluble Nanoscale CIGS Photoactive Functional MaterialsTargeting HIV-1 integrase with strand transfer inhibitors.Dynamics of conserved waters in human Hsp90: implications for drug designAurora-A kinase inhibitor scaffolds and binding modes.In-silico prediction of blood-brain barrier permeability.Prediction of aqueous solubility of organic compounds based on a 3D structure representation.Classification of Mixtures of Chinese Herbal Medicines Based on a Self-organizing Map (SOM).Support Vector Machine (SVM) Models for Predicting Inhibitors of the 3' Processing Step of HIV-1 Integrase.QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM).Using Support Vector Machine (SVM) for Classification of Selectivity of H1N1 Neuraminidase Inhibitors.Predicting the standard enthalpy (deltaH0f) and entropy (S0) of alkanes by artificial neural networks.Computational models on quantitative prediction of bioactivity of HIV-1 integrase 3' processing inhibitors.Quantitative structure and bioactivity relationship study on HCV NS5B polymerase inhibitors.Prediction of bioactivity of HIV-1 integrase ST inhibitors by multilinear regression analysis and support vector machine.Prediction of activity cliffs using support vector machines.Classification of Plasmodium falciparum glucose-6-phosphate dehydrogenase inhibitors by support vector machine.Prediction of sweetness by multilinear regression analysis and support vector machine.Using self-organizing map (SOM) and support vector machine (SVM) for classification of selectivity of ACAT inhibitors.Discriminating of ATP competitive Src kinase inhibitors and decoys using self-organizing map and support vector machine.Prediction of bioactivity of ACAT2 inhibitors by multilinear regression analysis and support vector machine.Carcinogenicity prediction of noncongeneric chemicals by a support vector machine.Classification of Aurora kinase inhibitors by self-organizing map (SOM) and support vector machine (SVM).Classification of acetylcholinesterase inhibitors and decoys by a support vector machine.In silico prediction of rhabdomyolysis of compounds by self-organizing map and support vector machine.Prediction of biological activity of Aurora-A kinase inhibitors by multilinear regression analysis and support vector machine.Classification of Aurora-A Kinase Inhibitors Using Self-Organizing Map (SOM) and Support Vector Machine (SVM).Explorations into modeling human oral bioavailability.Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.QSAR study on the antimalarial activity of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.Computer modeling in predicting the bioactivity of human 5-lipoxygenase inhibitors.SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors.Modeling of Gibbs energy of formation of organic compounds by linear and nonlinear methods.Quantitative structure and bioactivity relationship study on human acetylcholinesterase inhibitors.An optimum fermentation model established by genetic algorithm for biotransformation from crude polydatin to resveratrol.Similarity perception of reactions catalyzed by oxidoreductases and hydrolases using different classification methods.Research and prediction of coordination reactions between CPA-mA and some metal ions using artificial neural networks.Linear and nonlinear functions on modeling of aqueous solubility of organic compounds by two structure representation methodsDiscriminating of HMG-CoA reductase inhibitors and decoys using self-organizing maps
P50
Q33250222-F9F9AF95-0C8F-4635-BD75-7E88D993CB09Q33908941-7FD72A8B-4AA7-4F51-9731-4F78D51FB845Q33967494-0066CC70-1624-4162-8742-C03673E0591AQ35500226-8F9C7928-E4B7-4FCE-9DF9-36F7C48916B9Q36980659-D14F1325-83B8-4B44-ADF0-E35FB15CB2AFQ37819342-9980C375-1C5F-4BD6-BEFF-4DF9A34D83D6Q38423066-CE553339-B84F-469C-96D3-0F74880BF1DFQ38452717-B90D291F-551E-407C-9D3A-E9B3EA55C2C2Q39523702-BDF0AAF6-7375-4A0C-B859-3D2A785253F2Q39537136-DFA37AE2-EA78-41D0-AF9F-06AE35044689Q40202517-09A16986-8B14-408F-AA31-14CABF1467A4Q40635774-64A0F315-7E2E-4903-820D-0CA38B12E348Q40749942-4F3D118B-7554-4FA3-8432-2AE20F9E5224Q42200070-C870781B-E48F-4ABB-B09E-2524099CD01CQ42252644-3CDE983B-868B-4A53-8F1D-71C5AE80E803Q44528756-FAF0C3A0-647C-41BC-A4A9-47767BD6BF84Q44696233-82241462-0B53-4B9B-9EF8-CBCADFA2C467Q44764940-AB460091-6F2C-424E-905C-E1941C8ABE90Q44800812-99EAD802-C68E-4AC6-B34B-5F76F1C8E6B9Q44976261-4DF63AE4-15E7-4700-8F8F-CB0647F6894AQ45960008-5D6BE2E3-20C0-4980-B112-C1144A2F7DDAQ47233154-FD034157-71E1-407E-8DF6-7243BB52F5C9Q47241859-E0A387AA-01C5-41E6-81CD-2805C3DCAA07Q47297814-AC79580B-62AA-4588-B8CD-61589CF5DC3CQ47330635-08989BF5-227D-41CC-8FEF-F4BC62250DE7Q47359820-A276A9EB-0E44-47A5-ADE8-BB41019D2FCBQ47385712-CE4F5792-20E0-4C73-92E4-B06EE41902E5Q47396117-280CCC00-4B0E-4889-87C8-FA89BFAB8233Q47592559-5A21426A-4C62-40DE-9B31-7FBFA0A9CD15Q47830210-CBE9BECF-3508-47D6-836A-3ED9DF56751BQ47949539-7BB7ABD7-F5FA-4039-AD8C-C00C5DB82F38Q50541287-205D1592-D9AD-4D41-A3D0-BD0DE0DA257CQ50990911-E904740C-6B80-4B88-B8AE-ED140CD88A5FQ51100819-A404041E-A84D-48F6-BEDE-E396546B706CQ51392808-BC82E2DF-CF82-4AAB-9C0E-389C3F0B6B94Q51499172-4E68C0F8-4D1D-43BF-8BFC-5A9C50BF536AQ51693333-2063D0E4-64F4-43F9-8815-148B3A85D281Q52124566-034C186A-51E1-4F9E-B243-976F00560B22Q80405218-42B734B1-86B0-4A7F-9122-437ECD67F614Q82436515-50745C4B-C58C-49D6-A919-4CB21FC078A6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Aixia Yan
@ast
Aixia Yan
@en
Aixia Yan
@es
Aixia Yan
@nl
Aixia Yan
@sl
type
label
Aixia Yan
@ast
Aixia Yan
@en
Aixia Yan
@es
Aixia Yan
@nl
Aixia Yan
@sl
prefLabel
Aixia Yan
@ast
Aixia Yan
@en
Aixia Yan
@es
Aixia Yan
@nl
Aixia Yan
@sl
P108
P106
P1153
35197459200
P31
P496
0000-0003-4811-8510